After months in slow motion, there is a marked increase in the distribution of Pfizer’s antiviral in local pharmacies. As anticipated in recent days, the increase in new cases and a different distribution by age group is favoring a greater use of the drug. Mandelli (Fofi): “These data confirm the fundamental contribution of pharmacists to protect the health of citizens even in this new phase of the pandemic”.
24 JUNE –
In the latest AIFA update on the monitoring of the use of antivirals against Covid, there is a strong increase in the distribution of Paxlovid, Pfizer’s antiviral which, if used within five days of the onset of symptoms, is able to prevent the risk of hospitalization by 80% , by the local pharmacies.
There has been an 81.99% increase in pharmacy prescriptions and distributions in the past three weeks. The total number of Paxlovid treatments prescribed thus rose to 24,225.
The numbers seem to confirm what he told us just three days ago Pier Luigi Bartoletti, Provincial Secretary of Fimmg Rome and Deputy National Secretary of Fimmg, according to whom in recent days “the cases are rapidly increasing and the average age of positives is rising”. Hence the use of a greater number of prescriptions than in the previous period when to receive a positive swab were mostly “young and healthy people, therefore not suitable for receiving Paxlovid, or the elderly with a complicated health picture with many comorbidities for which monoclonal antibodies were preferred “.
“The data released by Aifa on the increase in antiviral drugs withdrawn directly from patients in pharmacies are a very positive signal and confirm the fundamental contribution of pharmacists in protecting the health of citizens even in this new phase of the pandemic”, he comments Andrea Mandellipresident of the Federation of the Orders of Italian Pharmacists (Fofi).
“The dispensing of antivirals by the proximity pharmacist – continues Mandelli – takes place absolutely free, without any burden for the NHS: as happened from the very first days of the pandemic, pharmacists have once again made available to the health system and of citizens their skills and their widespread presence on the territory to ensure accessibility and the necessary timeliness of treatments against Covid “.
“The experience of the antiviral Paxlovid confirms the need to expand the use of the distribution regime on behalf of those medicines that do not require hospital monitoring, in line with the relaunch of proximity care and protection of the right to health of all citizens ”, Concludes President Fofi.
June 24, 2022
© All rights reserved
Other articles in Science and Drugs
QS Edizioni srl
Via Boncompagni, 16
00187 – Roma
Via Vittore Carpaccio, 18
00147 Roma (RM)
Francesco Maria Avitto
Copyright 2013 © QS Edizioni srl. All rights reserved
– P.I. 12298601001
– registration in the ROC n. 23387
– registration at the Court of Rome n. 115/3013 of 22/05/2013
All rights reserved.